BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 21825122)

  • 1. Structural and functional characterization of a single-chain peptide-MHC molecule that modulates both naive and activated CD8+ T cells.
    Samanta D; Mukherjee G; Ramagopal UA; Chaparro RJ; Nathenson SG; DiLorenzo TP; Almo SC
    Proc Natl Acad Sci U S A; 2011 Aug; 108(33):13682-7. PubMed ID: 21825122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of CD4+ T cell-specific epitopes of islet-specific glucose-6-phosphatase catalytic subunit-related protein: a novel beta cell autoantigen in type 1 diabetes.
    Mukherjee R; Wagar D; Stephens TA; Lee-Chan E; Singh B
    J Immunol; 2005 May; 174(9):5306-15. PubMed ID: 15843527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxin-coupled MHC class I tetramers can specifically ablate autoreactive CD8+ T cells and delay diabetes in nonobese diabetic mice.
    Vincent BG; Young EF; Buntzman AS; Stevens R; Kepler TB; Tisch RM; Frelinger JA; Hess PR
    J Immunol; 2010 Apr; 184(8):4196-204. PubMed ID: 20220085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and therapeutic control of diabetogenic CD8+ T cells.
    Santamaria P
    Novartis Found Symp; 2008; 292():130-6; discussion 136-45, 202-3. PubMed ID: 19209463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-A*0201-restricted T cells from humanized NOD mice recognize autoantigens of potential clinical relevance to type 1 diabetes.
    Takaki T; Marron MP; Mathews CE; Guttmann ST; Bottino R; Trucco M; DiLorenzo TP; Serreze DV
    J Immunol; 2006 Mar; 176(5):3257-65. PubMed ID: 16493087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ recognition of autoantigen as an essential gatekeeper in autoimmune CD8+ T cell inflammation.
    Wang J; Tsai S; Shameli A; Yamanouchi J; Alkemade G; Santamaria P
    Proc Natl Acad Sci U S A; 2010 May; 107(20):9317-22. PubMed ID: 20439719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of β cell-specific human cytotoxic T cells by lentiviral transduction and their survival in immunodeficient human leucocyte antigen-transgenic mice.
    Babad J; Mukherjee G; Follenzi A; Ali R; Roep BO; Shultz LD; Santamaria P; Yang OO; Goldstein H; Greiner DL; DiLorenzo TP
    Clin Exp Immunol; 2015 Mar; 179(3):398-413. PubMed ID: 25302633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local autoantigen expression as essential gatekeeper of memory T-cell recruitment to islet grafts in diabetic hosts.
    Alkemade GM; Clemente-Casares X; Yu Z; Xu BY; Wang J; Tsai S; Wright JR; Roep BO; Santamaria P
    Diabetes; 2013 Mar; 62(3):905-11. PubMed ID: 23160528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalent CD8(+) T cell response against one peptide/MHC complex in autoimmune diabetes.
    Anderson B; Park BJ; Verdaguer J; Amrani A; Santamaria P
    Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9311-6. PubMed ID: 10430939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the beta cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes.
    Lieberman SM; Evans AM; Han B; Takaki T; Vinnitskaya Y; Caldwell JA; Serreze DV; Shabanowitz J; Hunt DF; Nathenson SG; Santamaria P; DiLorenzo TP
    Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8384-8. PubMed ID: 12815107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGRP and insulin vaccination induce CD8+ T cell-mediated autoimmune diabetes in the RIP-CD80GP mouse.
    Fuchs YF; Adler K; Lindner A; Karasinsky A; Wilhelm C; Weigelt M; Balke H; Förtsch K; Mortler-Hildebrandt LF; Harlan DM; Pechhold K; Ziegler AG; Bonifacio E
    Clin Exp Immunol; 2014 May; 176(2):199-206. PubMed ID: 24387268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP.
    Krishnamurthy B; Dudek NL; McKenzie MD; Purcell AW; Brooks AG; Gellert S; Colman PG; Harrison LC; Lew AM; Thomas HE; Kay TW
    J Clin Invest; 2006 Dec; 116(12):3258-65. PubMed ID: 17143333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of "Humanized" diabetogenic CD8 T-cell responses in HLA-transgenic NOD mice by a multipeptide coupled-cell approach.
    Niens M; Grier AE; Marron M; Kay TW; Greiner DL; Serreze DV
    Diabetes; 2011 Apr; 60(4):1229-36. PubMed ID: 21346176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidental CD8 T cell reactivity against caspase-cleaved apoptotic self-antigens from ubiquitously expressed proteins in islets from prediabetic human leucocyte antigen-A2 transgenic non-obese diabetic mice.
    Coppieters KT; Amirian N; von Herrath MG
    Clin Exp Immunol; 2011 Aug; 165(2):155-62. PubMed ID: 21605113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individual nonobese diabetic mice exhibit unique patterns of CD8+ T cell reactivity to three islet antigens, including the newly identified widely expressed dystrophia myotonica kinase.
    Lieberman SM; Takaki T; Han B; Santamaria P; Serreze DV; DiLorenzo TP
    J Immunol; 2004 Dec; 173(11):6727-34. PubMed ID: 15557165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantifying the importance of pMHC valency, total pMHC dose and frequency on nanoparticle therapeutic efficacy.
    Sugarman J; Tsai S; Santamaria P; Khadra A
    Immunol Cell Biol; 2013 May; 91(5):350-9. PubMed ID: 23528729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developmental control of CD8 T cell-avidity maturation in autoimmune diabetes.
    Han B; Serra P; Yamanouchi J; Amrani A; Elliott JF; Dickie P; Dilorenzo TP; Santamaria P
    J Clin Invest; 2005 Jul; 115(7):1879-87. PubMed ID: 15937548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling competition among autoreactive CD8+ T cells in autoimmune diabetes: implications for antigen-specific therapy.
    Marée AF; Santamaria P; Edelstein-Keshet L
    Int Immunol; 2006 Jul; 18(7):1067-77. PubMed ID: 16728432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chimeric antigen receptor (CAR) T cells targeting a pathogenic MHC class II:peptide complex modulate the progression of autoimmune diabetes.
    Zhang L; Sosinowski T; Cox AR; Cepeda JR; Sekhar NS; Hartig SM; Miao D; Yu L; Pietropaolo M; Davidson HW
    J Autoimmun; 2019 Jan; 96():50-58. PubMed ID: 30122420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early autoimmune destruction of islet grafts is associated with a restricted repertoire of IGRP-specific CD8+ T cells in diabetic nonobese diabetic mice.
    Wong CP; Li L; Frelinger JA; Tisch R
    J Immunol; 2006 Feb; 176(3):1637-44. PubMed ID: 16424193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.